From: The impact of HIV on the prevalence of asthma in Uganda: a general population survey
PLHIV (N = 103) | Not PLHIV (N = 1964) | P-value | |
---|---|---|---|
Characteristic | |||
Male gender, n(%) | 31 (30.1) | 763 (38.8) | 0.076 |
Age groups n(%) | < 0.001 | ||
< 15 | 1 (1.0) | 91 (4.6) | |
15–24 | 10 (9.7) | 474 (24.1) | |
25–34 | 27 (26.2) | 510 (25.9) | |
35–44 | 33 (32.0) | 388 (19.7) | |
45–54 | 27 (26.2) | 304 (15.5) | |
55–64 | 4 (3.9) | 131 (6.7) | |
65+ | 1 (1.0) | 68 (3.5) | |
Respiratory Symptoms n(%) | |||
Cough | 23 (22.3) | 404 (20.6) | 0.665 |
Sputum | 7 (6.8) | 140 (7.1) | 0.900 |
Wheezing | 11 (10.7) | 131 (6.7) | 0.116 |
Shortness of breath | 18 (17.5) | 177 (9.0) | 0.004 |
Risk factors and co-morbid conditions n (%) | |||
History of smoking | 13 (12.6) | 155 (7.9) | 0.086 |
Exposure to bio-mass | 24 (23.3) | 385 (19.6) | 0.357 |
Ever been treated for TB | 10 (9.7) | 30 (1.5) | < 0.001 |
Allergy | 42 (40.8) | 721 (36.7) | 0.400 |
Family history of asthma | 15 (14.6) | 220 (11.2) | 0.295 |